Bromperidol
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| 4-[4-(4-bromophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)butan-1-one | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Pregnancy cat. | ? |
| Legal status | ? |
| Routes | Oral |
| Identifiers | |
| CAS number | 10457-90-6 |
| ATC code | N05AD06 |
| PubChem | CID 2448 |
| ChemSpider | 2354 |
| UNII | LYH6F7I22E |
| KEGG | D01101 |
| ChEMBL | CHEMBL28218 |
| Chemical data | |
| Formula | C21H23BrFNO2 |
| Mol. mass | 420.315 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
Bromperidol (Bromidol) is a drug which is a butyrophenone derivative. It is a potent and long-acting neuroleptic, used as an antipsychotic in the treatment of schizophrenia. It was discovered at Janssen Pharmaceutica in 1966.
[edit] References
- Poldinger W, Bures E, Haage H, Clinical study with bromperidol, a new butyrophenone derivative, Int Pharmacopsychiatry. 1977;12(1):20-4.
- Dubinsky B, McGuire JL, Niemegeers CJ, Janssen PA, Weintraub HS, McKenzie BE, Bromperidol, a new butyrophenone neuroleptic: a review, Psychopharmacology (Berl). 1982;78(1):1-7.
|
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |

